KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network

KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA network

Pancreatic adenocarcinoma (PAAD) remains challenging to diagnose and treat clinically due to its difficult early diagnosis, low surgical resection rate, and high risk of postoperative recurrence and metastasis. SMAD4 is a classical mutated gene in pancreatic cancer and is lost in up to 60%–90 % of P...

Full description

Bibliographic Details
Main Authors: Meng Zhang, Lin Jiang, Xin-Yun Liu, Fu-Xing Liu, Hui Zhang, Yan-Juan Zhang, Xiao-Mei Tang, Yu-Shui Ma, Hui-Yi Wu, Xun Diao, Chun Yang, Ji-Bin Liu, Da Fu, Jie Zhang, Hong Yu
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Heliyon
Subjects:
ceRNA
PAAD
KLK10
LIPH
PARD6B
SMAD4
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024003189

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024003189

Similar Items